<bill session="118" type="s" number="2044" updated="2025-11-19T02:34:15Z">
  <state datetime="2023-06-20">REFERRED</state>
  <status>
    <introduced datetime="2023-06-20"/>
  </status>
  <introduced datetime="2023-06-20"/>
  <titles>
    <title type="display">End Price Gouging for Medications Act</title>
    <title type="short" as="introduced">End Price Gouging for Medications Act</title>
    <title type="official" as="introduced">A bill to require the Secretary of Health and Human Services to establish reference prices for prescription drugs for purposes of Federal health programs, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="M001176"/>
  <cosponsors>
    <cosponsor bioguide_id="W000800" joined="2023-06-20"/>
  </cosponsors>
  <actions>
    <action datetime="2023-06-20">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-06-20" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills>
    <bill session="118" type="h" number="4215" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Asia"/>
    <term name="Australia"/>
    <term name="Canada"/>
    <term name="Civil actions and liability"/>
    <term name="Europe"/>
    <term name="France"/>
    <term name="Germany"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Inflation and prices"/>
    <term name="Italy"/>
    <term name="Japan"/>
    <term name="Medicaid"/>
    <term name="Medical research"/>
    <term name="Medicare"/>
    <term name="Military medicine"/>
    <term name="Netherlands"/>
    <term name="North America"/>
    <term name="Oceania"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
    <term name="Spain"/>
    <term name="Sweden"/>
    <term name="Switzerland"/>
    <term name="United Kingdom"/>
    <term name="Veterans' medical care"/>
  </subjects>
  <amendments/>
  <summary date="2023-07-26T18:10:00Z" status="Introduced in Senate">End Price Gouging for Medications Act

This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including the lowest retail price for a drug among specified reference countries.

Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.</summary>
</bill>
